| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Insidertrades | Knock-outs | myfinanzen |
| Orderbuch | Realtime Stuttgart | RSS Feed | Analyse | im Forum | Fonds | Senden |
| Historisch | Realtime Push | IR-Daten | Anleihen | handeln | ||
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| RBC Capital Markets | 15,00$ | +57,73% | 13.01.12 | |||
| Stifel, Nicolaus & Co., Inc. | 15,00$ | +57,73% | 22.11.11 | |||
| Citigroup Corp. | 12,00$ | +26,18% | 27.10.11 | |||
| Robert W. Baird & Co. Incorporated | 19,00$ | +99,79% | 27.10.11 | |||
| Credit Suisse Group | 27,00$ | +183,91% | 29.08.11 | |||
| Barclays Capital | 42,00$ | +341,64% | 18.04.11 |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Amgen Inc. | 5 | 9 | 1 | 68,33 $ | +1,47% |
| Celgene Corp. | 8 | 0 | 0 | 79,67 $ | +11,04% |
| GlaxoSmithKline plc (GSK) | 6 | 8 | 2 | 14,48 £ | +2,62% |
| Merck Co. | 2 | 3 | 0 | 38,50 $ | +1,56% |
| Novartis AG | 11 | 6 | 2 | 56,62 | +10,59% |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 8 | 1 | 0 | 58,50 $ | +32,44% |